European Journal of Pharmaceutics and Biopharmaceutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 5.0 | Q1 | 80.6% | 0.848 | Q1 | 79.2% |
| 2024 | 4.3 | Q1 | 80.7% | 0.905 | Q1 | 81.6% |
| 2023 | 4.4 | Q1 | 82.8% | 0.835 | Q1 | 81.0% |
| 2022 | 4.9 | Q1 | 82.5% | 0.830 | Q1 | 81.5% |
| 2021 | 5.6 | Q1 | 82.6% | 0.857 | Q1 | 83.0% |
| 2020 | — | — | 1.103 | Q1 | 87.4% | |
| 2019 | — | — | 1.059 | Q1 | 86.9% | |
| 2018 | — | — | 1.326 | Q1 | 89.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
0939-6411
ISSN
1873-3441
country
NLcoverage
1991-2026